Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
Breast Cancer Research and Treatment|December 15, 2012
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancerMassimo Cristofanilli, Stephen R D Johnston, Alexey Manikhas, et al.
Breast Cancer (Dove Medical Press)|December 11, 2024
Psychological Stress and Its Correlations to Patients with Acute Lymphedema After Breast Cancer SurgeryLi-Ping Ge, Lichen Tang, WenJia Zuo, et al.
Cell Death & Disease|February 9, 2018
Targeting deubiquitinase USP28 for cancer therapyXiaofang Wang, Zhiyi Liu, Li Zhang, et al.
Theranostics|May 4, 2018
CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcriptionSheng Huang, Yayun Chi, Yi Qin, et al.
Clinical and Translational Radiation Oncology|November 12, 2024
Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trialXiaomeng Zhang, Xiaofang Wang, Yajuan Chu, et al.
The Oncologist|June 12, 2025
Pegylated liposomal doxorubicin + cyclophosphamide followed by taxane as adjuvant therapy for early-stage breast cancer: a randomized controlled trialLichen Tang, Min He, Cuizhi Geng, et al.
Therapeutic Advances in Medical Oncology|October 28, 2024
Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2-, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE studyQingyuan Zhang, Kunwei Shen, Chuan-Gui Song, et al.
International Journal of Clinical Oncology|May 7, 2026
The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina studyTao Huang, Zhimin Fan, Yongsheng Wang, et al.
Nature Communications|July 12, 2022
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancerBiyun Wang, Tao Sun, Yannan Zhao, et al.
Cancer Medicine|March 20, 2015
Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtypeXiaoyan Huang, Matteo Dugo, Maurizio Callari, et al.
Pageof 21